相关实验视频
Updated: Jun 6, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
低糖是什么时候NPO? 与儿科手术前低血糖相关的患者变量
Gretchen Rogers1, Jenny Beitz1, Shara Griffin1
1Department of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
概括
儿科手术前低血糖症可能与年龄,麻醉风险和糖尿病病史有关. 需要进一步的研究来确认这些儿童的危险因素.
科学领域:
- 儿科麻醉学 儿科麻醉学
- 临床研究 临床研究
- 患者安全 患者安全
背景情况:
- 儿科患者手术前低血糖症可能导致不良后果.
- 识别风险因素对于预防和管理至关重要.
研究的目的:
- 确定与儿科手术患者手术前低血糖相关的人口和患者特异性因素.
- 为了将低血糖儿科患者的特征与一般的外科患者进行比较.
主要方法:
- 在手术前治疗低血糖症的儿科患者的回顾性图表审查.
- 评估了10个变量,包括年龄,性别,体重,禁食时间,ASA状态,外科服务,肠道准备,并发症和糖尿病史.
- 与数据可用的医院的整体外科患者人群进行比较.
主要成果:
- 在低血糖和一般手术群体之间,种族,性别或手术内并发症没有显著差异.
- 观察到的年龄,美国麻醉学会 (ASA) 状态,糖尿病/低血糖病史,手术类型 (GI/肺部) 和低血糖事件发生时间的显著差异.
- 在低血糖组中发现了体重,手术前肠道清理和禁食时间的趋势.
结论:
- 年龄,ASA状态,糖尿病史,特定的手术和事件发生的时间是儿科手术前低血糖的潜在危险因素.
- 追溯性限制了最终的结论;需要进一步的研究来验证这些发现.
- 需要进行额外的研究来确认已识别的风险因素,并探索其他可能导致儿科手术前低血糖症的潜在因素.
相关概念视频
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
SBAR II: Application of SBAR
4.3K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.3K
Oral Hypoglycemic Agents: Glinides
141
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
141
Insulin: Dosing Regimen and Adverse Effects
145
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
145
Pathophysiology of Diabetes
868
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
868
Parenteral Anesthetics: Overview
100
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
100

